儿童心胸外科术后声带麻痹管理的标准化
这项前瞻性队列研究在三级转诊中心纳入128例1岁以内接受主动脉弓相关心胸外科手术的患儿,实施标准化多学科方案管理单侧声带麻痹(UVFI)。45例UVFI患儿中17例接受注射喉成形术(IL),IL组出院时经口进食 Advancement 比例高于保守组(100% vs 64.3%),但组间基线特征存在差异,结局差异不能完全归因于治疗选择。
要点
- 1岁以内主动脉弓手术后UVFI发生率为35.1%(45/128)。
- IL组出院时经口进食进展率100%(17/17),保守组64.3%(18/28)。
- IL组鼻胃管拔除中位时间30天,保守组58天。
核心结论
- 实施心胸外科术后UVFI临床路径可能标准化治疗与结局评估。
- 本队列中IL患者较保守治疗者更常在术后近期实现经口进食进展。
- 但组间基线临床特征与治疗选择相关,结局差异不能单独归因于治疗选择。
研究设计与样本
- 前瞻性队列研究,在三级转诊中心开展。
- 纳入2015年8月至2024年9月期间1岁或以下接受涉及主动脉弓的心胸外科手术的患者。
- 共纳入128例患者,女性53例(41.4%),男性75例(58.6%),中位年龄17天(IQR 6-87天)。
- 排除手术时校正年龄≤36周、术前诊断吞咽困难、因临床恶化未完成术后喂养评估及在初次住院外接受IL的患者。
- 45例(35.1%)发生UVFI,其中17例接受IL,28例未接受。
主要发现
- IL组出院时经口进食进展17/17(100%),非IL组18/28(64.3%),差异35.7%(95%CI 12%-54%)。
- IL组14例(82%)带鼻胃管出院,非IL组18例(64%),差异18%(95%CI -9%至40%)。
- IL组与非IL组鼻胃管拔除中位时间分别为30天(IQR 24.5)和58天(IQR 89.5),差异-28天。
- IL组与非IL组住院中位时间分别为28天(IQR 14.0)和23天(IQR 19.5),差异5天。
临床怎么用
- 对心胸外科术后1岁以内患儿可考虑实施标准化多学科UVFI管理路径。
- IL可能有助于加速经口进食进展和缩短鼻胃管依赖时间,但需结合基线特征个体化评估。
- 结局差异不能仅归因于治疗选择,临床决策需考虑组间基线差异。
局限性
- 组间基线临床特征与治疗选择相关,存在选择偏倚。
- 非随机设计,观察到的结局差异不能完全归因于治疗方式。
- 单中心三级转诊中心研究,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Unilateral vocal fold immobility (UVFI) is a common complication of cardiothoracic surgery in pediatric populations, yet no standardized treatment guidelines exist. The current literature supporting pediatric injection laryngoplasty (IL) has been limited by heterogeneity in patient populations, treatment approaches, and outcomes analysis. OBJECTIVE: To implement a standardized, multidisciplinary protocol for managing pediatric UVFI after cardiothoracic surgery and describe recovery patterns and outcomes observed among patients treated with IL vs conservative approaches. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study was conducted at a tertiary care referral center and included patients who were undergoing cardiothoracic surgery involving the aortic arch at age 1 year or younger between August 2015 and September 2024. Data were analyzed from September 2024 to October 2024. Patients with adjusted age of 36 weeks or younger at the time of surgery or a preoperative diagnosis of dysphagia were excluded. Additional exclusion criteria removed patients who did not complete postoperative feeding evaluations due to clinical decline and those who underwent IL outside the initial admission after cardiothoracic surgery. EXPOSURE: Injection laryngoplasty. MAIN OUTCOMES AND MEASURES: The primary outcome was oral diet advancement at time of discharge after cardiothoracic surgery, which was defined by improvement in frequency, volume, or consistency of oral intake. Secondary outcomes included nasogastric feeding tube (NGT) requirements, rate of gastrostomy tube placement, and hospital length of stay. RESULTS: A total of 128 patients (53 [41.4%] female and 75 [58.6%] male; median [IQR] age, 17 [6-87] days) were included. Of the 45 patients (35.1%) with UVFI, 17 underwent IL and 28 did not. More IL patients achieved oral diet advancement by discharge compared with non-IL patients (17 of 17 [100%] vs 18 of 28 [64.3%]; difference, 35.7%; 95% CI, 12%-54%). Fourteen IL patients (82%) were discharged with an NGT vs 18 (64%) non-IL patients (difference, 18%; 95% CI, -9% to 40%). The median (IQR) time to NGT removal for IL vs non-IL patients was 30 (24.5) days vs 58 (89.5) days (difference, -28 days), and the median (IQR) hospital length of stay for IL vs non-IL patients was 28 (14.0) vs 23 (19.5) days (difference, 5 days). CONCLUSIONS AND RELEVANCE: Implementing a clinical pathway for managing UVFI after cardiothoracic surgery may standardize treatment and outcome assessment. In this cohort study, IL patients more frequently achieved oral diet advancement during the immediate postoperative period than those treated conservatively. However, these groups differed in baseline clinical characteristics that were associated with treatment selection; therefore, the observed differences in outcomes cannot be attributed to treatment choice alone.
引用
- Nelson L, Belsky MA, Meister KD, et al. Standardizing Management of Pediatric Vocal Fold Immobility After Cardiothoracic Surgery. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 41746635. doi:10.1001/jamaoto.2026.0001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。